|
 |
TacrolimusThis page contains recent news articles, when available, and an overview of Tacrolimus but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Tacrolimus (when available) Tacrolimus, a macrolide immunosuppressant produced by Streptomyces tsukubaensis, is an immunosuppressive agent indicated for the treatment of patients receiving kidney and/or liver transplants. Tacrolimus has been demonstrated to suppress humoral immunity and, to a greater extent, cell-mediated reactions such as allograft rejection, delayed type hypersensitivity, collagen- induced arthritis, experimental allergic encephalomyelitis, and graft versus host disease. It has similar immunosuppressive properties to cyclosporine, but is much more potent in equal volumes. Tacrolimus is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver or kidney transplants. Used in a topical preparation in the treatment of severe atopic dermatitis, also used after bone marrow transplants and for severe refractory uveitis. Mechanism Of Action: Tacrolimus inhibits T-lymphocyte activation by first binding to an intracellular protein, FKBP-12. A complex of Tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin is then formed and the phosphatase activity of calcineurin is inhibited. This prevents the dephosphorylation and translocation of nuclear factor of activated T-cells (NF-AT), a nuclear component thought to initiate gene transcription for the formation of lymphokines. Tacrolimus also inhibits the transcription for genes which encode IL-3, IL-4, IL-5, GM-CSF, and TNF-, all of which are involved in the early stages of T-cell activation. Additionally, Tacrolimus has been shown to inhibit the release of pre-formed mediators from skin mast cells and basophils, and to downregulate the expression of FceRI on Langerhans cells. News Articles on Tacrolimus Psoriasis may be a systemic disease - Jan 4, 2010 Calcineurin inhibitors -- tacrolimus and pimecrolimus -- can help reduce inflammation and skin cell buildup. Ultraviolet light slows the rapid growth of ... UPI.com LifeCycle Pharma submits Phase 3 Protocol for LCP-Tacro to FDA - Dec 23, 2009 LCP-Tacro is being developed by the company as a once daily tablet version of tacrolimus, with improved bioavailability and reduced peak-to-trough ... Trading Markets (press release) LifeCycle Pharma submits phase-3 protocol for LCP – Tacro to US FDA - Dec 28, 2009 Tacrolimus is a leading immunosuppression drug used for the prevention of transplant allograft rejection after organ transplantation. ... pharmabiz.com RX for Readers: On the other hand - Jan 1, 2010 Typical treatments include topical corticosteroids or topical inflammatory medications called calcineurin inhibitors such as tacrolimus or pimecrolimus. ... Jerusalem Post This (transplanted) life - Dec 11, 2009 Twice a day I take Tacrolimus, a miracle drug discovered by the Japanese in soil samples in 1975. It's expensive and if I had to pay the full cost it would ... The Australian Graft-Versus-Host Disease: Failures and Future Opportunities - Dec 10, 2009 The primary pharmacological strategy to prevent GVHD is the use of cyclosporine and tacrolimus in combination with other immunosuppressants. ... Seeking Alpha (blog) Zevalin® (Ibritumomab Tiuxetan) Demonstrated Activity in Several ... - Dec 11, 2009 Tacrolimus and methotrexate were used for GVHD prophylaxis. Median time to ANC >500 was 11(range, 8-17) days, and to platelets > 20000/mm3 was 10 (range, ... Benzinga One in five heart-transplant patients get skin cancer within five years - Dec 29, 2009 Tacrolimus and sirolimus were nonsignificantly correlated with a decreased risk of basal-cell and squamous-cell carcinomas, respectively. ... TheHeart.Org ä¸åŒ–æ?¶æ?å…?疫抑制劑商機 - Dec 29, 2009 ...æž—è¡›ç?†è¡¨ç¤ºï¼Œå¡”克莫å?¸è—¥ç‰©ï¼ˆTacrolimus Capsule）å?¯ä»¥é˜»æ¢é«”內產生淋巴細胞，以防æ¢æ–°å™¨å®˜å?—æ??，其普é??用於腎臟ã€?è‚?臟ç‰å™¨å®˜ç§»æ¤?手術後，å?¯èƒ½ç”¢ç”Ÿå°?移æ¤?器官的排斥å??應 ... 中時電子報 Astellas Pharma set to launch Prograf in India, works on marketing strategy - Nov 12, 2009 Prograf (tacrolimus) has similar immunosuppressive properties to cyclosporin, the commonly used drug to stop organ rejection. However, studies showed that ... pharmabiz.com LifeCycle Pharma Announces Result for the First Nine Months of 2009 and ... - Nov 12, 2009 ...phase of the study to have a potential best-in-class profile when compared to the currently marketed twice daily tacrolimus capsule, Prograf(R). ... Benzinga Astellas wins Japanese approval for additional indication of Prograf - Oct 19, 2009 Tacrolimus is an immunosuppressant discovered and developed by Astellas and is marketed as an immunosuppressant for organ transplantation under the brand ... Trading Markets (press release) Hikma Pharmaceuticals PLC - Interim Management Statement - Nov 11, 2009 ...promotion agreement with Astellas for Advagraf, a modified-release, once-daily formulation of Prograf, Astellas' leading immunosuppressant tacrolimus. ... Zawya New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for ... - Oct 26, 2009 Concomitant tacrolimus use may increase tacrolimus whole blood concentrations. Please see the complete prescribing information and visit the KAPIDEX Web ... Reuters US: “Health benefits and risks of grapefruit and grapefruit juiceâ€? - Nov 12, 2009 ...cyclosporine, ethinyl, estradiol, felodipine, lovastatin, nifedipine, nimodipine, saquinavir, simvastatin, tacrolimus, testosterone, triazolam. ... FreshPlaza Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? - Oct 27, 2009 The drugs cyclosporine A (CsA) and tacrolimus (FK506) revolutionized organ transplantation. Both compounds are still widely used in the clinic as well as ... 7thSpace Interactive (press release) Choice of Calcineurin Inhibitor Does Not Influence Outcome of Liver ... - Nov 5, 2009 Results from 310 patients who underwent liver transplantation between 2001 and 2007 and were given tacrolimus (TAC) or cyclosporine (CSA) for ... DG News Commercial Insight - Solid organ transplantation - The impact of new biologics ... - Oct 23, 2009 However, the combined sales of Astellas´s tacrolimus franchise (Prograf and once-daily Advagraf) will dominate the immunosuppressant market over the next ... PR-Inside.com (Pressemitteilung) Cinacalcet Effective for Refractory Hyperparathyroidism - Nov 1, 2009 Seventeen patients were on cyclosporine, five were on tacrolimus, and two were on everolimus. The patients had a mean age of 56 years. ... Renal and Urology News Astellas licenses Medivation's prostate cancer candidate - Oct 28, 2009 ...by analysts at Barclays Capital to "underweight" from "equal weight", on the basis of generic competition to its transplant drug Prograf (tacrolimus). ... Pharma Times Astellas counts the cost of Prograf generic - Nov 6, 2009 Sales edged up 0.3% to 494.64 billion yen, driven by Prograf (tacrolimus). However sales of the drug were down 1.3% to 103.00 billion yen, as Novartis unit ... Pharma Times FDA Safety Changes: Ultram, Ultracet, Sustiva, Kayexalate - Oct 28, 2009 ...such as cyclosporine, sirolimus, and tacrolimus. Dose adjustments may be required, and immunosuppressant concentrations should be monitored closely for ... Medscape Autoimmune hepatitis - Nov 3, 2009 Other alternatives include cyclophosphamide, methotrexate, cyclosporin A and tacrolimus. All of these agents have been only been tested in small trials. ... OnMedica BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to ... - Oct 31, 2009 ...a liver transplant recipient who has received or is receiving an immunosuppressant that may affect renal function, such as cyclosporine or tacrolimus. ... Reuters Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide - Nov 9, 2009 Astellas has discovered an over-active bladder (OAB) medication, Vesicare® and an immunosuppressive agent, Prograf® (tacrolimus), which have enabled them to ... SYS-CON Media (press release) PRESS RELEASE: Novartis Delivers Strong New -3- - Oct 21, 2009 ...consecutive quarter in 2009 of year-on-year growth thanks to new product launches, including a first-to-market launch of generic tacrolimus (Prograf®). ... Capital.gr (press release) Dermatite atopica: in autunno peggiora, ma ci sono novità - Nov 4, 2009 Oggi però l'EMEA ha approvato il primo inibitore topico della calcineurina, tacrolimus unguento, per il trattamento di mantenimento dell'eczema contro nuove ... Sanihelp.it Novartis T3: performance hétérogène divisions non pharma - Sandoz en bonne voie - Oct 21, 2009 ...mêmes trimestres de 2008, grâce au lancement de nouveaux produits, comprenant Prograf, le premier générique de tacrolimus à être lancé sur le marché. ... Romandie.com Schuppenflechte-Therapie - Oct 26, 2009 Eine schulmedizinische Alternative bieten seit rund zehn Jahren die Wirkstoffe Tacrolimus und Pimecrolimus. Ursprünglich wurden diese sogenannten ... FAZ - Frankfurter Allgemeine Zeitung æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...ìš°ì„ ë‚´ë…„ì—? '노보믹스'(NovoMix, insulin aspart), 'ì•…í† ë„¬'(Actonel, risedronate), 'ì„¸ë ˆë²¤íŠ¸'(Serevent, salmeterol), '프로그ëž?'(Prograf, tacrolimus)ì?˜ 특허가 ... 디지틀보사 Wirbel um Regividerm - Oct 22, 2009 Calicineurininhibitoren ( Wirkstoffe: Pimecolimus und Tacrolimus) die nach 10-jähriger Forschungsarbeit und nach allen erforderlichen Studiendurchläufen ... die-news.de Premian un trabajo andaluz sobre trasplante hepático y mejora de la ... - Oct 29, 2009 ...efecto adverso atribuible al uso prolongado de los inhibidores de la calcineurina (tacrolimus y ciclosporina, ambas terapias clave en la reducción de la ... ADN.es DJ HUGIN NEWS/Novartis verzeichnet in den ersten -6- - Oct 21, 2009 Dazu gehörte unter anderem die erste Markteinführung einer generischen Version von Tacrolimus (Prograf®). In Mittel- und Osteuropa wurden kräftige Zuwächse ... unternehmer.de Roche says combining CellCept, tacrolimus boosts transplanted kidney ... - Oct 19, 2005 ZURICH (AFX) - Roche Holding AG said that an analysis of over 44500 US kidney transplant recipients has shown a significant increase in the lifespan of ... Forbes Is tacrolimus superior to ciclosporin microemulsion in preventing... - Jul 6, 2005 Krämer BK et al. (2005) Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. ... Nature.com Toxic serum levels of tacrolimus after topical administration in an... - Jun 4, 2007 Previous reports have been published of increased cutaneous absorption of tacrolimus in children with concomitant conditions associated with a skin-barrier ... Nature.com Long-term tacrolimus versus long-term ciclosporin in renal transplant... - Jul 7, 2008 Low-dose tacrolimus, as part of a triple-therapy regimen, can lead to stabilization of renal graft function even in patients with poor renal function at ... Nature.com Tacrolimus ointment vs steroid ointment for eyelid dermatitis in... - May 5, 2006 Correspondence: Dr E Nivenius, Department of Clinical Neuroscience, Karolinska Institutet, Division of Ophthalmology, St Erik's Eye Hospital, ... Nature.com Tacrolimus or microemulsified ciclosporin for immunosuppression after... - Feb 28, 2007 O'Grady J et al. (2007) Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance ... Nature.com Is cyclosporin or tacrolimus treatment most beneficial after liver … - Jul 21, 2006 McAlister VC et al. (2006) Cyclosporin versus tacromilus as primary immunosuppressant after liver transplantation: a meta-analysis. ... Nature.com … diabetes after renal transplantation: comparing ciclosporin and... - Aug 15, 2007 Meta-analyses and registry data imply that tacrolimus is associated with a greater ... To compare the effects of ciclosporin and tacrolimus on the rate of ... Nature.com Is tacrolimus associated with fewer surgical complications than … - Jul 12, 2005 Steurer W et al. (2005) Spectrum of surgical complications after simultaneous pancreas–kidney transplantation in a prospectively randomized study of two ... Nature.com Is tacrolimus effective for treating antisynthetase-associated... - Aug 29, 2005 Wilkes MR et al. (2005) Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 52: 2439–2446 PubMed ... Nature.com … -convenient 1 mg/ml suspension of tacrolimus for accurate maintenanc... - Mar 6, 2006 Oral preparations of tacrolimus are commercially available in 0.5, ... We postulated that a 1 mg/ml oral formulation of tacrolimus would decrease the ... Nature.com Long-Term Intermittent Tacrolimus Thwarts Flares in Paediatric Atopic... - Sep 18, 2008 By Jill Stein. PARIS -- September 18, 2008 -- Long-term, intermittent, once-daily therapy with tacrolimus ointment is a viable and effective disease ... DG News Can tacrolimus replace ciclosporin and prednisone to treat myasthenia... - Jul 1, 2005 Ponseti JM et al. (2005) Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis. Neurology 64: 1641–1643 PubMed ... Nature.com Bayer obtains rights to new cancer, transplantation drug tests from... - Jan 30, 2006 The transplantation drug test, tacrolimus, will be complimentary to Bayer's cyclosporine, ... The tacrolimus test is designed to determine the amount of ... Forbes Learn about Tacrolimus from Consumer Reports Health. - Jan 6, 2008 Tacrolimus should only be given under the supervision of a doctor who is experienced in treating ... Full Alert. Tacrolimus is used along with other ... consumerreports.org … and pharmacogenomic analysis of tacrolimus in pediatric living... - Feb 13, 2006 The Bayesian prediction for tacrolimus concentrations was not significantly biased on any postoperative day, and the mean absolute prediction error was ... Nature.com … early steroid withdrawal after liver transplantation feasible with... - Nov 21, 2007 ...(2007) Tacrolimus monotherapy without steroids after liver ... All patients received basic immunosuppressive therapy with tacrolimus (0.2 mg/kg per day, ... Nature.com Tacrolimus for induction therapy of diffuse proliferative lupus... - Jan 23, 2005 Correspondence: Chi Chiu Mok MD, FRCP, Senior Medical Officer (Rheumatology), Department of Medicine & Geriatrics, Tuen Mun Hospital, New Territories, ... Nature.com Intermittent Topical Tacrolimus Therapy Gives Control of Atopic... - Jul 23, 2007 July 23, 2007 (Chicago) -- Tacrolimus ointment is more effective than vehicle in preventing relapses of childhood atopic dermatitis and did not produce ... Medscape Tacrolimus Topical Side Effects from Consumer Reports Health. - Jan 7, 2006 A small number of patients who used tacrolimus ointment or another similar medication developed skin ... Full Alert. A small number of patients who used ... consumerreports.org … -to-Head Clinical Trial of LCP-Tacro versus Advagraf(R), Both Tacrol... - Sep 5, 2007 Tacrolimus is a leading immunosuppressive medication to prevent rejection ... Transplant patients need to maintain a minimum level of tacrolimus in the ... Genetic Engineering News - Genetic Engineering News (press release) Generic Tacrolimus Leads to Poorer Clinical Outcomes in Adult, … - Aug 14, 2008 By Rachel Parratt. SYDNEY, Australia -- August 14, 2008 -- Patients receiving the generic formulation of tacrolimus (Tenacrine) after first renal transplant ... DG News Tacrolimus Is Safe and Effective in Patients with Severe Steroid- … - Jun 26, 2005 Correspondence: Axel U Dignass, MD, PhD, Department of Medicine, I, Markus-kronkenhaus, Academic Teaching Hospital of the Johann-Wolfgang-Goethe-Universität ... Nature.com Lifecycle Pharma presents positive phase 1 data on transplantation … - May 31, 2007 LCP-Tacro is being developed as a once-daily tablet version of tacrolimus, an immunosuppressive drug used to reduce the risk of organ rejection in ... Forbes Cyclosporine Shows Advantage Over Tacrolimus - Jan 6, 2006 The immunosuppressive agent cyclosporine has shown better efficacy than the leading anti-rejection drug tacrolimus when taken as an adjunctive therapy by ... RedOrbit LifeCycle Says its Tacro Transplant Drug Betters Astellas's - Jul 8, 2008 Liver transplant patients who took LCP-Tacro, a once-daily version of the tacrolimus medicine, were able to take a smaller dose than patients who took ... Bloomberg Tacrolimus/MMF Safe, More Effective in Cardiac Transplant - Apr 8, 2005 April 8, 2005 (Philadelphia) — Among cardiac transplant recipients, the combination of tacrolimus and mycophenolate mofetil (MMF) results in fewer ... Medscape Tacrolimus prevents flares in atopic dermatitis.(Skin Disorders) - Oct 1, 2007 CHICAGO -- Intermittent treatment with tacrolimus ointment kept atopic dermatitis under control with no need for corticosteroids in patients aged 2-15 years ... Free with registration - Family Practice News - AccessMyLibrary.com Astellas Receives FDA Approval of Prograf(R) (Tacrolimus) for Use in ... - Mar 31, 2006 DEERFIELD, Ill., March 31 /PRNewswire/ -- The Food and Drug Administration (FDA) has granted Astellas Pharma US, Inc. approval for the use of Prograf as an ... RedOrbit Tacrolimus Injection Side Effects from Consumer Reports Health. - Jan 6, 2008 Tacrolimus injection should only be given under the supervision of a doctor who is experienced in ... Full Alert. Tacrolimus injection should only be given ... consumerreports.org Action Letter Issued for FK506 (Tacrolimus) - Jan 23, 2007 The FDA has issued an action letter to Astellas Pharma for its NDA for FK506 modified-release formulation (tacrolimus). FK506 has received approvable ... Facts and Comparisons Tacrolimus and Pimecrolimus for Atopic Dermatitis - Nov 14, 2005 Question: For adults and children with atopic dermatitis, which are more effective and better tolerated in reducing the signs and symptoms of atopic ... Archives of Dermatology Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates … - Feb 20, 2006 Sorin Group, Europe's largest medical technology company specialising in the treatment of cardiovascular diseases, presented last week the first six-month ... RedOrbit Tacrolimus: A New Therapy For Steroid Resistant Nephrotic Syndrome In... - May 30, 2008 UroToday.com - A study by Gulati, et al evaluated the safety and efficacy of tacrolimus (TAC) in children with steroid-resistant nephrotic syndrome. ... Medical News Today - Medical News Today (press release) Tacrolimus (Systemic). - Oct 27, 2005 Tacrolimus (ta-KROE-li-mus) belongs to a group of medicines known as immunosuppressive agents. It is used to lower the body's natural immunity in patients ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com AASLD: Spare the Tacrolimus and Save the Kidneys - Nov 4, 2007 By Neil Osterweil, Senior Associate Editor, MedPage Today. BOSTON, Nov. 4 -- For liver transplant recipients, lowering the dose and delaying the ... MedPage Today … Patient, Graft Survival With Sirolimus Plus Tacrolimus Regimen in... - Aug 14, 2008 The randomised, open-label, comparative study compared the efficacy of 2 sirolimus regimens versus mycophenolate mofetil (MMF) plus tacrolimus. ... DG News Pre-tacrolimus topical steroid benefit affirmed. - May 1, 2006 Koloa, Hawaii -- The popular offlabel practice of prescribing a few days of topical steroids prior to starting tacrolimus for atopic dermatitis is ... Free with registration - Pediatric News - AccessMyLibrary.com Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer ... - Apr 26, 2005 Reason for posting: Many patients with eczema, or atopic dermatitis, are prescribed the topical immunomodulators tacrolimus and pimecrolimus. ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com Extended-Release Tacrolimus Appears Safe, Effective - May 7, 2007 May 7, 2007 (San Francisco) — Patients undergoing transplantation may soon benefit from a less expensive, simpler immunosuppressive regimen, according to ... Medscape Trial boost for kidney transplant patients - Jul 25, 2006 After one year, patients taking CellCept plus the immune suppresser tacrolimus showed a 15% improvement in kidney function. ... WalesOnline Pimecrolimus and Tacrolimus: The US FDA Public Health Advisory: AAD … - Mar 28, 2005 After the FDA decision was announced, Clay J. Cockerell, MD, president of the American Academy of Dermatology responded, "The Academy is disappointed that ... Medscape Tacrolimus 0.03% Ointment Effective as Second-Line Treatment in … - May 21, 2007 By Chris Berrie. VIENNA, AUSTRIA -- May 21, 2007 -- The immunosuppressant tacrolimus provides a safe and effective topical treatment when compared with the ... DG News … Function Better on Low-Level Tacrolimus Regimen Than Cyclosporine:... - Jul 26, 2006 By Ed Susman. BOSTON, MA -- July 26, 2006 -- Maintenance of a lower trough level of tacrolimus results in better functioning kidney grafts than standard ... DG News … Randomised Trial of Tacrolimus, Azathioprine and Prednisolone With... - Aug 18, 2008 A total of 192 children and adolescents undergoing renal transplantation were randomly chosen to receive tacrolimus, azathioprine and corticosteroids (TAS, ... UroToday International Journal Renal Transplantation; Tacrolimus-based immunosuppression reviewed - Mar 14, 2005 2005 MAR 14 - (NewsRx.com) -- A researcher reviews tacrolimus-based immunosuppression in a recent issue of the Journal of Nephrology. ... Pay-Per-View - Obesity & Diabetes Week - Factiva, from Dow Jones Article: Intermittent tacrolimus may prevent AD flares.(Clinical... - Oct 1, 2007 Intermittent tacrolimus may prevent AD flares.(Clinical Rounds) ... find Pediatric News articles. CHICAGO -- Intermittent treatment with tacrolimus ointment ... Pay-Per-View - Pediatric News - HighBeam Research Tacrolimus after transplant tied to diabetes risk.(Nephrology) - Sep 15, 2006 BOSTON -- Use of tacrolimus after kidney transplantation may be a risk factor for new-onset diabetes and impaired fasting glucose that should be considered ... Free with registration - Internal Medicine News - AccessMyLibrary.com TradeName : Pangraf, Vingraf, Prograf, Protopic, Tacromus - Dec 31, 2008 Why it is prescribed (Indications) : Tacrolimus is used to prevent rejection of Kidney, ... The grapefruit increases plasma-tacrolimus concentration. ... MedIndia Tacrolimus ( Topical). - Oct 27, 2005 Tacrolimus ( ta-KROE-li-mus) ointment is used for moderate to severe atopic dermatitis. This is a skin condition where there is itching, ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Article: Long-term tacrolimus use prevents AD flares.(Clinical... - Nov 1, 2007 Long-term tacrolimus use prevents AD flares.(Clinical Rounds) ... find Pediatric News articles. NEW YORK -- Long-term use of tacrolimus ointment was ... Pay-Per-View - Pediatric News - HighBeam Research Black box warning added to pimecrolimus, tacrolimus labels.(News) - Feb 15, 2006 The US Food and Drug Administration last month approved updated health-professional labels for pimecrolimus and tacrolimus that include a new black box ... Free with registration - Family Practice News - AccessMyLibrary.com Calcineurin-Inhibitor Withdrawal May Improve Renal Allograft Outcomes - Jun 19, 2008 Estimated total lifetime costs were $472799 with the sirolimus-steroids regimen, $484020 with cyclosporine, and $505420 with tacrolimus. ... MedPage Today Tacrolimus effective for skin allergy in kids - Sep 14, 2005 NEW YORK (Reuters Health) - Treatment with an ointment containing tacrolimus, an immune-suppressing drug, relieves mild-to-moderate eczema in children, ... RedOrbit Ongoing study suggests tacrolimus is safe for kids.(Skin Disorders) |... - Mar 1, 2007 Ongoing study suggests tacrolimus is safe for kids.(Skin Disorders) ... find Family Practice News articles. WASHINGTON -- Preliminary data from an ongoing ... Pay-Per-View - Family Practice News - HighBeam Research Low-Dose Tacrolimus Appears to Fare Best in Symphony Trial: Presented... - Jul 26, 2006 By Ed Susman. BOSTON, MA -- July 26, 2006 -- A comparison of 4 different methods of immunosuppression for transplant patients indicates that a low-dose ... DG News Tacrolimus cream. - Jan 1, 2008 Ortonne JP, van de Kerkhof PC, Prinz JC, et al; European Tacrolimus Psoriasis ... 0.3% Tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to ... $9.94 - Formulary - Alacra Store Renal Transplantation; Tacrolimus-based immunosuppression reviewed - Mar 18, 2005 2005 MAR 18 - (NewsRx.com) -- A researcher reviews tacrolimus-based immunosuppression in a recent issue of the Journal of Nephrology. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Low-Dose Tacrolimus Superior to Other Immunosuppressives After Renal … - Aug 2, 2006 August 2, 2006 (Boston) --- When compared with standard and low-dose immunosuppression regimens in renal transplant patients, low-dose tacrolimus results in ... Medscape Tacrolimus Effective for Pityriasis alba - Dec 1, 2006 Synopsis: P. alba is characterized by hypopigmented macules and is associated with atopic dermatitis. Because tacrolimus is an effective treatment for the ... AAFP News Now Early data confirm the safety of tacrolimus.(News)(Clinical report) |... - Mar 1, 2007 Early data confirm the safety of tacrolimus.(News)(Clinical report) ... find Pediatric News articles. Washington -- Preliminary data from an ongoing ... Pay-Per-View - Pediatric News - HighBeam Research Majority of high-risk cornea grafts successful with systemic tacrolimu... - Feb 14, 2007 A majority of patients who received systemic tacrolimus underwent successful ... All patients took 2 mg of oral tacrolimus on the day of surgery and ... OSN SuperSite Tacrolimus cream is safe, effective for psoriasis.(Dermatologic... - Apr 1, 2007 WASHINGTON -- Tacrolimus cream appears to be effective and safe for the treatment of mild to moderate plaque psoriasis in adults, Dr. J. Michael Maloney ... Free with registration - Skin & Allergy News - AccessMyLibrary.com Tacrolimus Effective as Steroid Sparing Agent - Oct 16, 2007 A study of Chinese adult patients suggests that a 24-week course of tacrolimus is a favorable steroid-sparing drug for treating steroid-dependent minimal ... Renal and Urology News Off-label use of tacrolimus, pimecrolimus grows.(Rx) - Feb 1, 2005 VIENNA -- The topical calcineurin inhibitors constitute the most important advance in topical therapy of inflammatory dermatoses in half a century, ... Free with registration - Internal Medicine News - AccessMyLibrary.com … : Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates … - Feb 20, 2006 Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety Profile and Clinical Efficacy in "Real-World" Patients, Particularly in Those ... Pay-Per-View - PR Newswire - HighBeam Research Tacrolimus for the Treatment of Primary Sclerosing Cholangitis - May 29, 2007 Jayant A. Talwalkar; Andrea A. Gossard; Jill C. Keach; Roberta A. Jorgensen; Janice L. Petz; RN Keith D. Lindor. Background: Results from a pilot ... Medscape … Laboratory Products Recalls Tacrolimus Active Pharmaceutical... - May 19, 2006 BETHESDA, MD -- May 19, 2006 -- Spectrum Laboratory Products and the US Food and Drug Administration (FDA) notified pharmacists and organ transplantation ... DG News Once-a-Day or Twice-Daily Tacrolimus as Effective as Cyclosporine in ... - Aug 3, 2006 BOSTON, MA -- August 3, 2006 -- Study results presented today at the World Transplant Congress (WTC) demonstrated that investigational drug, ... DG News Topical tacrolimus found to reduce vitiligo size.(Dermatologic... - Aug 1, 2007 Topical tacrolimus found to reduce vitiligo size.(Dermatologic Therapy) ... find Skin & Allergy News articles. TORONTO -- Topical tacrolimus significantly ... Pay-Per-View - Skin & Allergy News - HighBeam Research What is the role of tacrolimus and pimecrolimus in atopic dermatitis?(... - Aug 1, 2005 When the standard therapies--mild topical corticosteroids and moisturizers--fail in the treatment of atopic dermatitis, patients are left with few proven ... $4.95 - Journal of Family Practice - ECNext Immunosuppressant Kit facilitates tacrolimus monitoring. - Aug 1, 2007 August 1, 2007 - Along with liquid chromatography (LC)/mass spectrometry (MS) systems and clinical service and support, MassTrak(TM) provides complete ... ThomasNet Industrial News Room - ThomasNet Industrial News Room (press... Tacrolimus Cream Appears Effective for Mild to Moderate Psoriasis... - Feb 6, 2007 By Bruce Sylvester. WASHINGTON, DC -- February 6, 2007 -- Twice daily applications of tacrolimus cream 0.1% and 0.5% are safe and effective for the ... DG News … diabetes mellitus is associated with high tacrolimus concentration... - Mar 14, 2006 Tacrolimus is a strong immunosuppressive drug associated with low acute rejection rates, ... "High trough levels of tacrolimus during the first month after ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Dade Behring Launches Tacrolimus Test on Its Dimension(R), V-Twin(R),... - Jul 19, 2006 Dade Behring Inc. (NASDAQ:DADE), the world's largest company solely dedicated to clinical diagnostics, today announced that it has launched the Tacrolimus ... RedOrbit Alemtuzumab and Tacrolimus Monotherapy - Sep 12, 2008 Ron Shapiro, MD, Professor of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania; Director of Kidney, Pancreas & Islet Transplantation, ... Medscape Are Tacrolimus and Pimecrolimus Effective for Psoriasis? - Mar 1, 2005 Synopsis: Investigators randomized 167 patients with facial or intertriginious nonplaque-type psoriasis in a double-blind fashion to receive 0.1 percent ... AAFP News Now Tacrolimus, UVB therapy synergistic duo.(Clinical Dermatology) - May 1, 2005 Nice, France -- Results of a comparative, prospective, randomized study undertaken by French dermatologists indicate that topical tacrolimus ointment 0.1 ... Free with registration - Dermatology Times - AccessMyLibrary.com Topical tacrolimus found to reduce vitiligo size.(Dermatologic... - Aug 1, 2007 TORONTO -- Topical tacrolimus significantly decreased the size of vitiligo lesions and spurred repigmentation, compared with pretreatment and unaffected ... Free with registration - Skin & Allergy News - AccessMyLibrary.com LifeCycle Pharma Initiates Phase II Clinical Trial for LCP-Tacro, an ... - Dec 3, 2007 Tacrolimus is a leading immunosuppressive medication to prevent rejection ... Transplant patients need to maintain a minimum level of tacrolimus in the ... Genetic Engineering News - Genetic Engineering News (press release) Tacrolimus prevents flares in atopic dermatitis.(Skin Disorders) |... - Oct 1, 2007 Tacrolimus prevents flares in atopic dermatitis.(Skin Disorders) ... find Family Practice News articles. CHICAGO -- Intermittent treatment with tacrolimus ... Pay-Per-View - Family Practice News - HighBeam Research LifeCycle Pharma Announces Positive Results From Head-to-Head … - Nov 7, 2007 Tacrolimus is a leading immunosuppressive medication to prevent rejection after organ transplantation. LCP-Tacro is being developed as a once-daily tablet ... Genetic Engineering News - Genetic Engineering News (press release) LifeCycle Pharma To Initiate Phase II Clinical Trial Of LCP-Tacro For... - Jun 22, 2007 Tacrolimus is a leading immunosuppressive medication to prevent rejection ... Transplant patients need to maintain a minimum level of tacrolimus in the ... Medical News Today - Medical News Today (press release) Sucampo voluntarily suspends tacrolimus eye drops program - Jul 6, 2005 Sucampo Pharmaceuticals Inc., Bethesda, MD, said it has voluntarily suspended its tacrolimus eye drops development program due to FDA safety concerns about ... Ophthalmology Times Long-term use of tacrolimus for AD flares found to reduce relapse... - Oct 1, 2007 Long-term use of tacrolimus for AD flares found to reduce relapse risk.(Atopic Dermatitis) ... find Skin & Allergy News articles. NEW YORK -- Long-term use ... Pay-Per-View - Skin & Allergy News - HighBeam Research Tacrolimus ointment effective in treatment of allergic contact... - Oct 1, 2006 A recent study evaluated 0.1% tacrolimus ointment in the treatment of nickel-induced allergic contact dermatitis (ACD). In this study, patients with nickel ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Tacrolimus, pimecrolimus black box challenged.(News) - May 1, 2005 MAUI, HAWAII -- The American Academy of Dermatology and other professional groups maintain that insufficient evidence exists to justify the Food and Drug ... Free with registration - Pediatric News - AccessMyLibrary.com Adverse Drug Reaction; CV monitoring may be necessary in tacrolimus- … - Nov 1, 2005 ..."Tacrolimus at 0.025 mg kg-1 increased HR and inotropy with continued ... "Tacrolimus significantly prolonged the QT interval (QTc) between doses of 0.0125 ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Long-term tacrolimus use prevents AD flares.(Clinical Rounds) - Nov 1, 2007 NEW YORK -- Long-term use of tacrolimus ointment was effective in managing atopic dermatitis and preventing disease flares in a group of adults and children ... $4.95 - Pediatric News - ECNext Study Demonstrates Improved Renal Function and Lipid Values in Kidney... - Jul 25, 2006 Tacrolimus as Secondary Intervention vs. Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure: Five Year Results ... Free with registration - PR Newswire - AccessMyLibrary.com Diagnostics; Method for simultaneous measure of whole blood tacrolimus... - Jun 20, 2005 ..."Context-Combined immunosuppressant therapy using tacrolimus and sirolimus has ... Simultaneous chromatographic monitoring of whole blood tacrolimus and ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Diagnostics; Method for simultaneous measure of whole blood tacrolimus... - Jun 21, 2005 ..."Context-Combined immunosuppressant therapy using tacrolimus and sirolimus has ... Simultaneous chromatographic monitoring of whole blood tacrolimus and ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones JUPITER II: Janus Tacrolimus-Eluting Stent vs Tecnic Carbostent - Oct 5, 2005 The Janus stent (Sorin Biomedica, Italy) uses a new technology specifically designed with grooves that serve as reservoirs on the external surface of the ... Medscape Topical tacrolimus for the treatment of lichen sclerosus.(PIPELINE … - Jan 1, 2007 The results of a Phase II multicenter clinical trial that assessed the safety and efficacy of topical tacrolimus ointment 0.1% in the treatment of lichen ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Sirolimus and Tacrolimus Without Methotrexate Appear Promising for … - Dec 12, 2005 By Bruce Sylvester. ATLANTA, GA -- December 12, 2005 -- Immunosuppressants sirolimus (Rapamycin) and tacrolimus (Prograf) used without methotrexate appear ... DG News Tacrolimus effective. - Oct 1, 2005 New York -- Treatment with an ointment containing tacrolimus relieves mild-to-moderate eczema in children, according to a report in the journal Pediatrics. ... Free with registration - Dermatology Times - AccessMyLibrary.com … flares controlled with intermittent tacrolimus use.(Pediatric... - Sep 1, 2007 CHICAGO -- Intermittent treatment with tacrolimus ointment kept atopic dermatitis under control with no need for corticosteroids in children and adolescents ... $4.95 - Skin & Allergy News - ECNext Study shows tacrolimus better for atopic dermatitis.(Skin Disorders) - Jan 1, 2005 NEW YORK -- Tacrolimus proved to be more efficacious and no more irritating than pimecrolimus in the first large head-to-head comparison of the two topical ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Tacrolimus cream is safe, effective for psoriasis.(Dermatologic... - Apr 1, 2007 Tacrolimus cream is safe, effective for psoriasis.(Dermatologic Therapy) ... find Skin & Allergy News articles. WASHINGTON -- Tacrolimus cream appears to be ... Pay-Per-View - Skin & Allergy News - HighBeam Research … : Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates … - Feb 20, 2006 Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety Profile and Clinical Efficacy in "Real-World" Patients, Particularly in Those ... Pay-Per-View - PR Newswire Europe - HighBeam Research Brand Names/Synonyms: Tacrolimus is also known by the following brand names and/or synonymsFK 506; FK-506; FK5; K506; Prograf; Protopic; Tacarolimus; Tacrolimus Drug Category: Tacrolimus is categorized under the following by the FDA: Immunosuppressive Agents; ATC:D11AX14; ATC:L04AA05 Dosage Forms: CAPSULE; OINTMENT; SOLUTION Absorption: Generally incomplete with absolute bioavailability of 17-22% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3- [2-(4-hydroxy-3-methoxycyclohexyl) -1-methylethenyl]-14, 16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15, 19-epoxy-3H-pyrido[2,1-c][1,4] oxaazacyclotricosine-1,7,20, 21(4H,23H)-tetrone, monohydrate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |